TLSI vs PMA Comparison

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

PMA Graphene Technology Group Inc, formerly Ming Shing Group Holdings Ltd, is a holding company engaged in wet trades works, including plastering, tile laying, brick laying, floor screeding and marble works. To a much lesser extent, it provides small-scale fitting out services, such as renovation works, and engages in trading of wines and spirits. Through its subsidiaries, it is mainly engaged in private sector projects in Hong Kong, involving private residential and commercial developments, while public sector projects mainly involve public residential developments, infrastructure and public facilities developments. The Company operates through two segments: Provision of Wet Trades Works and Trading of Wines and Spirits, with Trading of Wines and Spirits generating the maximum revenue.